jRCTs031220473
Untitled Trial
Achievement and its clinical significance of molecular remission induced by baricitinib treatment for active rheumatoid arthritis patients with methotrexate inadequate response (RA Be in Remission Study)
Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Rheumatoid arthritis
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs031220473
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs031220473 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.